Movatterモバイル変換


[0]ホーム

URL:


Journal Logo

Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.

Export to

OPINION

Adenovirus vectors as HIV-1 vaccines

where are we? What next?

D'Souza, Marie Patriciaa; Yang, Otto O.b , c

Author Information

aDivision of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland

bDivision of Infectious Diseases/Department of Medicine and Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California

cAIDS Healthcare Foundation, Los Angeles, California, USA.

Correspondence to Otto O. Yang, MD, Division of Infectious Diseases, BSRB 173, 615 Charles E Young Drive South, University of California Los Angeles, Los Angeles, CA 90095, USA. Tel: +1 310 794 9491; e-mail:[email protected].

Received 8 August, 2014

Revised 12 November, 2014

Accepted 13 November, 2014

AIDS29(4):p 395-400, February 20, 2015. |DOI:10.1097/QAD.0000000000000548
Copyright © 2015 Wolters Kluwer Health, Inc.

You can read the full text of this article if you:

Log InAccess through Ovid

Source

AIDS29(4):395-400, February 20, 2015.
Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.


[8]ページ先頭

©2009-2025 Movatter.jp